Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2024 Apr 2;17(4):e259485.
doi: 10.1136/bcr-2023-259485.

Acute quadruple extremity compartment syndrome due to angio-oedema after polypharmacy overdose including olmesartan medoxomil, telmisartan and vildagliptin

Affiliations
Case Reports

Acute quadruple extremity compartment syndrome due to angio-oedema after polypharmacy overdose including olmesartan medoxomil, telmisartan and vildagliptin

Yumi Kono et al. BMJ Case Rep. .

Abstract

This case report describes a rare manifestation of acute compartment syndrome (ACS) involving all four extremities, precipitated by angio-oedema in a middle-aged woman who consumed an overdose of multiple medications: nifedipine, azelnidipine, amlodipine besylate, olmesartan medoxomil, telmisartan, esaxerenone and vildagliptin. She presented with haemodynamic instability, necessitating intubation. Despite stabilising haemodynamic parameters within 24 hours, she manifested escalating extremity oedema. At 52 hours after ingestion, mottled skin was observed, along with necrotic alterations in the swollen hands and compartment pressures exceeding 30 mm Hg in all extremities. ACS was diagnosed, leading to fasciotomies. The aetiology is postulated to be drug-induced angio-oedema, possibly intensified by the concurrent overdose of olmesartan medoxomil, telmisartan and vildagliptin, each of which has a risk of angio-oedema even at standard dosages. This scenario is a very rare case caused by drug-induced angio-oedema, which underscores the importance of vigilant monitoring to detect ACS in patients with progressing limb oedema.

Keywords: Adult intensive care; Drug interactions; Drugs misuse (including addiction); Orthopaedic and trauma surgery.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Similar articles

References

    1. Depetri F, Tedeschi A, Cugno M. Angioedema and emergency medicine: from pathophysiology to diagnosis and treatment. Eur J Intern Med 2019;59:8–13. 10.1016/j.ejim.2018.09.004 - DOI - PubMed
    1. Caballero T, Baeza ML, Cabañas R, et al. . Consensus statement on the diagnosis, management, and treatment of angioedema mediated by bradykinin. part II. treatment, follow-up, and special situations. J Investig Allergol Clin Immunol 2011;21:422–41; . - PubMed
    1. Zuberbier T, Aberer W, Asero R, et al. . The EAACI/Ga2Len/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria. Allergy 2018;73:1393–414. 10.1111/all.13397 - DOI - PubMed
    1. Jaiganesh T, Wiese M, Hollingsworth J, et al. . Acute angioedema: recognition and management in the emergency Department. Eur J Emerg Med 2013;20:10–7. 10.1097/MEJ.0b013e328356f76e - DOI - PubMed
    1. Yusuf S, Teo KK, Pogue J, et al. . Telmisartan, Ramipril, or both in patients at high risk for vascular events. N Engl J Med 2008;358:1547–59. 10.1056/NEJMoa0801317 - DOI - PubMed

Publication types

LinkOut - more resources